Heart rate response to cannabis in active older adults
This study looked at older adults who were starting to use cannabis edible products for sleep, pain, or mood problems. Researchers checked their resting heart rate before and two hours after they ate a product, and measured THC in their blood.
Lower Pain Intensity Is Associated with the Use of Recreational Edible Cannabis Products Containing Delta-9-Tetrahydrocannabinol: A Secondary Analysis in Adults Self-Managing Their Chronic Low Back Pain
Researchers followed adults living with long-term lower back pain who chose to use edible cannabis products from legal stores over a two-week period. Participants filled out daily questionnaires about their pain levels, whether they consumed their cannabis product, how many times they used it, and the estimated amounts of plant compounds they took. The goal was to see how different mixtures of major cannabis plant compounds related to daily and short-term changes in pain.
Double-Blind, Randomized, Placebo-Controlled, Crossover Study of Oral Cannabidiol and Tetrahydrocannabinol for Essential Tremor
Older adults with severe shaking movements of the hands received daily oral capsules containing pharmaceutical grade plant extracts of tetrahydrocannabinol and cannabidiol, compared against identical inactive placebo capsules in a crossover design.
Working memory capacity predicts cannabis-induced effects on alcohol urge
This study looked at adults who drink heavily and also use cannabis regularly. Each person came to the lab on three separate days and smoked either a cannabis cigarette with no active ingredient, a weaker cigarette, or a stronger cigarette, and rated how strongly they wanted alcohol before and after.
Potency-related effects of smoked cannabis on simulated driving performance: a randomized, controlled crossover trial
Researchers in Toronto studied adults who use cannabis regularly and hold driver's licences. Each person sat in a driving simulator after smoking cannabis of different strengths, or a dummy product with no active ingredient, on separate days.
Investigating the effects of cannabinoids for the reduction of inflammation and sickle cell disease pain (CRISP); A protocol for a randomized double-blind placebo-controlled study
This is a plan for a study of adults with sickle cell disease who have long-lasting pain. Participants are randomly assigned to take a prescription synthetic form of the main active ingredient in cannabis (called dronabinol) or an inactive pill for eight weeks, and neither they nor the researchers know which one they receive.
Δ9-Tetrahydrocannabinol Alters Limbic and Frontal Functional Brain Connectomes Among Young Adult Cannabis Users
Researchers studied 33 healthy young adults in their early twenties who used cannabis occasionally. Each person took a capsule with a moderate amount of synthetic THC (the main intoxicating ingredient in cannabis, given as a prescription form) on one visit and an inactive capsule on another, and their brain activity was scanned at rest while they were high.
Results of an Exploratory Crossover Pharmacokinetic Study Evaluating a Natural Hemp Extract-Based Cosmetic Product: Comparison of Topical and Oral Routes of Administration
Twenty healthy adults took a hemp-derived oil product that contains a substance called cannabidiol, either by mouth or rubbed onto the skin, at different times. Blood was drawn over the following day to see how much of the substance entered the body by each route.
Nabiximols in Multiple Sclerosis: Beyond Spasticity-An Exploratory Systematic Review and Meta-Analysis of Symptomatic Outcomes
This review pooled results from many earlier studies of a mouth spray containing two cannabis compounds, called nabiximols, in adults with multiple sclerosis. The researchers looked at whether it helped with problems other than the muscle stiffness it is already approved for, such as bladder, sleep, muscle spasms and walking.
Evaluation of the use of different forms of medical cannabis in the treatment of fibromyalgia: a systematic review
Researchers reviewed the best available medical studies that tested cannabis-based medicines in people with a long-lasting condition that causes widespread body pain, poor sleep and tiredness. They looked at a few different versions of these medicines and compared them with dummy pills or standard painkillers.